4.8 Article

Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury

Journal

BIOMATERIALS
Volume 34, Issue 8, Pages 1987-1994

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.11.040

Keywords

Magnetic targeting; Stem cell; Nanoparticle; Restenosis; Catheter

Funding

  1. Rosetrees Trust
  2. Engineering and Physical Sciences Research Council (EPSRC)
  3. British Heart Foundation (BHF)
  4. Science Foundation Ireland (SFI), Strategic Research Cluster (SRC) [SFI: 09/SRC B1794]
  5. Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish
  6. EPSRC [EP/I014667/1] Funding Source: UKRI

Ask authors/readers for more resources

Vascular occlusion can result in fatal myocardial infarction, stroke or loss of limb in peripheral arterial disease. Interventional balloon angioplasty is a common first line procedure for vascular disease treatment, but long term success is limited by restenosis and neointimal hyperplasia. Cellular therapies have been proposed to mitigate these issues; however efficacy is low, in part due to poor cell retention. We show that magnetic targeting of mesenchymal stem cells gives rise to a 6-fold increase in cell retention following balloon angioplasty in a rabbit model using a clinically applicable permanent magnet. Cells labelled with superparamagnetic iron oxide nanoparticles exhibit no negative effects on cell viability, differentiation or secretion patterns. The increase in stem cell retention leads to a reduction in restenosis three weeks after cell delivery. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available